Clinical Trials History Medicine Topical 
The Cannigma
DECEMBER 12, 2022
And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming. Classical psychedelics
Cannabis Law Report
JULY 28, 2021
The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
NOVEMBER 27, 2021
Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” Medicines and Healthcare Products Regulatory Agency for one of its DMT products for the treatment of major depressive disorder.
The Cannigma
MAY 19, 2021
However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. In 2018, Epidolex became the first plant-derived cannabinoid prescription medicine to receive FDA approval. But in modern times? Shutterstock).
Medicinal Marijuana Association
FEBRUARY 11, 2024
The potential link between cannabis and glaucoma treatment is a topic of ongoing investigation, stirring both curiosity and caution within the medical community. Risk factors for glaucoma include age, family history, and certain medical conditions like diabetes and high blood pressure.
Cannabis Law Report
JUNE 19, 2022
Creating this infrastructure helps establish a system of values that shapes our goals and focuses our mission in strategic ways – all important steps given that the topic is so new,” Davis said. Our purpose as scholars and educators is to advance innovation in practice and widely disseminate it so that it touches many lives.
Cannabis Law Report
FEBRUARY 28, 2022
Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. Except for ketamine, an essential medicine used in anesthesia, 6 × 6. Quibell et al.,
Expert insights. Personalized for you.
119 
Let's personalize your content